World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
10178
World Ranking
4495
National Ranking
112

Thomas Eiwegger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas Eiwegger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas Eiwegger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Eiwegger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas Eiwegger is affiliated with the Hospital for Sick Children in Canada and has contributed extensively to the field of medicine, focusing primarily on immunology and allergy. Their research spans various subfields including physiology, pulmonary and respiratory medicine, dermatology, and surgery.

The main topics of their work cover:

  • Food Allergy and Anaphylaxis Research
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Eosinophilic Esophagitis
  • Drug-Induced Adverse Reactions
  • Contact Dermatitis and Allergies
  • Urticaria and Related Conditions

Their publication record includes a number of papers in prominent journals. Some recent notable papers include:

  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma," 2020, Allergy
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma," 2020, Allergy
  • "Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma," 2020, Allergy
  • "EAACI guidelines on the diagnosis of IgE-mediated food allergy," 2023, Allergy
  • "Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)," 2020, Allergy

Frequent coauthors collaborating with Thomas Eiwegger include:

  • Ioana Agache
  • Cezmi A. Akdiş
  • Marek Jutel
  • Julia Upton
  • Óscar Palomares

Their work is predominantly published in the following venues:

  • Allergy
  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Pediatric Allergy and Immunology
  • Allergy Asthma and Clinical Immunology

Best Publications

  • Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases

    Mübeccel Akdis;Simone Burgler;Reto Crameri;Thomas Eiwegger

  • Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

    Mübeccel Akdis;Alar Aab;Can Altunbulakli;Kursat Azkur

  • Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4

    Michael B. Soyka;Paulina Wawrzyniak;Thomas Eiwegger;Thomas Eiwegger;David Holzmann

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Exposure to household furry pets influences the gut microbiota of infants at 3–4 months following various birth scenarios

    Hein M. Tun;Theodore Konya;Tim K. Takaro;Jeffrey R. Brook

  • Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties.

    Thomas Eiwegger;Bernd Stahl;Paul Haidl;Joachim Schmitt

  • Human milk--derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro

    Thomas Eiwegger;Bernd Stahl;Joachim Schmitt;Günther Boehm

  • EAACI Biologicals Guidelines—Recommendations for severe asthma

    Ioana Agache;Cezmi Akdis;Mubeccel Akdis;Giorgio Walter Canonica

  • Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma

    Heimo Breiteneder;Ya Qi Peng;Ya Qi Peng;Ioana Agache;Zuzana Diamant;Zuzana Diamant

  • A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.

    Kerstin Tiringer;Angela Treis;Petra Fucik;Mia Gona

  • Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study.

    Maxwell M. Tran;Diana L. Lefebvre;Christoffer Dharma;David Dai

  • Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).

    Milena Sokolowska;Zuzanna M. Lukasik;Zuzanna M. Lukasik;Ioana Agache;Cezmi A. Akdis

  • Do lipids influence the allergic sensitization process

    Merima Bublin;Thomas Eiwegger;Heimo Breiteneder

  • TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis

    Maya Zimmermann;Andrea Koreck;Norbert Meyer;Tomasz Basinski;Tomasz Basinski

  • Modes of Infant Feeding and the Risk of Childhood Asthma: A Prospective Birth Cohort Study.

    Annika Klopp;Lorena Vehling;Allan B. Becker;Padmaja Subbarao

  • Fecal Short-Chain Fatty Acid Variations by Breastfeeding Status in Infants at 4 Months: Differences in Relative versus Absolute Concentrations.

    Sarah L. Bridgman;Meghan B. Azad;Catherine J. Field;Andrea M. Haqq

  • EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

    O Boyman;C Kaegi;M Akdis;S Bavbek

  • A compendium answering 150 questions on COVID-19 and SARS-CoV-2.

    Carmen Riggioni;Pasquale Comberiati;Pasquale Comberiati;Mattia Giovannini;Ioana Agache

  • Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.

    Ioana Agache;Yang Song;Pablo Alonso-Coello;Yasmin Vogel

  • EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.

    Milena Sokolowska;Thomas Eiwegger;Markus Ollert;Maria J Torres

  • IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma

    Thomas Eiwegger;Thomas Eiwegger;Cezmi A. Akdis

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Ioana Agache;Claudio Rocha;Jessica Beltran;Yang Song

Frequent Co-Authors

Cezmi A. Akdis
Cezmi A. Akdis University of Zurich
Marek Jutel
Marek Jutel Wrocław Medical University
Oscar Palomares
Oscar Palomares Complutense University of Madrid
Ioana Agache
Ioana Agache Transylvania University of Brașov
Liam O'Mahony
Liam O'Mahony University College Cork
Mübeccel Akdis
Mübeccel Akdis University of Zurich
Jürgen Schwarze
Jürgen Schwarze University of Edinburgh
Kari C. Nadeau
Kari C. Nadeau Harvard University
Oliver Pfaar
Oliver Pfaar Philipp University of Marburg
Heimo Breiteneder
Heimo Breiteneder Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their immunology expertise, pursuing related nursing degrees can open diverse career pathways. Many professionals choose specialized programs to enhance their clinical skills, such as the cheapest online pmhnp certificate programs, which offer affordable routes into psychiatric nursing, a field closely linked with immunological health.

Understanding salary prospects is crucial. Nurses with advanced degrees, such as a Doctor of Nursing Practice (DNP), can expect varying compensation depending on their specialty. Comprehensive data on dnp salary by specialty helps prospective students and practitioners evaluate career benefits nationally.

For Family Nurse Practitioners (FNPs) seeking to broaden their scope, obtaining acute care certification is a strategic move. Resources on acute care certification for fnp provide necessary guidance for transitioning into more specialized, high-demand roles.

Accelerated pathways are also available for those aiming to fast-track their careers. Exploring accelerated np programs can help motivated students complete their education efficiently while preparing for advanced clinical roles in immunology-related fields.

Best Scientists Citing Thomas Eiwegger

Trending Scientists

Recently Published Articles